Sun City, AZ2 Active Studies

Non-Alcoholic Fatty Liver Disease Clinical Trials in Sun City, AZ

Find 2 actively recruiting non-alcoholic fatty liver disease clinical trials in Sun City, AZ. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
5,850
Enrolling

Recruiting Non-Alcoholic Fatty Liver Disease Studies in Sun City

About Non-Alcoholic Fatty Liver Disease Clinical Trials in Sun City

Non-alcoholic fatty liver disease (NAFLD/MASLD) is a condition where excess fat builds up in the liver without significant alcohol consumption. It is the most common liver disease in Western countries. Management includes weight loss, exercise, and treatment of associated metabolic conditions.

There are currently 2 non-alcoholic fatty liver disease clinical trials recruiting participants in Sun City, AZ. These studies are seeking a combined 5,850 participants. Research is being sponsored by Eli Lilly and Company, 89bio, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.

Non-Alcoholic Fatty Liver Disease Clinical Trials in Sun City — FAQ

Are there non-alcoholic fatty liver disease clinical trials in Sun City?

Yes, there are 2 non-alcoholic fatty liver disease clinical trials currently recruiting in Sun City, AZ. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Sun City?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Sun City research site will contact you about next steps.

Are clinical trials in Sun City free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Sun City studies also compensate for your time and travel.

What non-alcoholic fatty liver disease treatments are being tested?

The 2 active trials in Sun City are testing new therapies including novel drugs, biologics, and treatment approaches for non-alcoholic fatty liver disease.

Data updated October 15, 2026 from ClinicalTrials.gov